4D Molecular Therapeutics (FDMT)
(Delayed Data from NSDQ)
$6.60 USD
-0.50 (-7.04%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $6.60 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, 4D Molecular Therapeutics, Inc. has a market cap of $331.59M, which represents its share price of $7.10 multiplied by its outstanding shares number of 46.70M. As a small-cap company, FDMT's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
FDMT 6.60 -0.50(-7.04%)
Will FDMT be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for FDMT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for FDMT
SNY's Gene Therapy Candidate for Eye Disease Gets FDA Fast Track Tag
4D Molecular Therapeutics, Inc. (FDMT) Reports Q2 Loss, Misses Revenue Estimates
FDMT: What are Zacks experts saying now?
Zacks Private Portfolio Services
4D Molecular Therapeutics, Inc. (FDMT) Reports Q1 Loss, Lags Revenue Estimates
4D Molecular Therapeutics, Inc. (FDMT) Reports Q3 Loss, Lags Revenue Estimates
ARS Pharmaceuticals, Inc. (SPRY) Reports Q3 Loss, Misses Revenue Estimates
Other News for FDMT
Is FDMT preparing to trend lower? Fell Below 20 Day Moving Average shows up after crashing 7.04%
H.C. Wainwright Reaffirms Their Buy Rating on 4D Molecular Therapeutics (FDMT)
Crossed Above 20 Day Moving Average appears for FDMT after 6.61% move
FDMT forms 20 Day Moving Average Resistance on September 17
FDMT forms 1,2,3 Pullback Bullish on September 16